title: Treatment of acute, severe epigastric/chest pain in a patient with stomach cancer following gastrectomy: A case report.
abstract: The treatment of acute chest pain can be a challenge in palliative care. Firstly, because acute chest pain is a symptom of a paucity of diseases, which makes diagnosis difficult and time consuming, while there is also a time constraint, due to the extreme suffering of the patient. Secondly, the condition of a patient with advanced cancer disease and co-morbidities does not always allow for required diagnostic procedures. The present report describes a case of acute, severe epigastric/chest pain in a patient with dynamic disease progression, who was receiving palliative care. This study also demonstrates that the pathophysiology of pain in a terminal patient may determine the treatment strategy. The patient in the present case was a 41-year-old male, who had previously undergone gastrectomy for stomach cancer, followed by postoperative chemotherapy. The patient was treated with palliative chemotherapy for metastases to the lungs, liver and lymph nodes, which led to the development of iatrogenic peripheral neuropathy. The patient was subsequently admitted to the Palliative Medicine In-patient Unit of the University Hospital of Lord's Transfiguration (Poznan, Poland) with the complaint of acute epigastric and chest pain. An electrocardiogram, echocardiogram, chest and abdomen computerized tomography scan, esophagoduodenoscopy and laboratory analyses were performed to determine the source of the pain. The patient was treated with morphine sulfate, metoclopramide, midazolam, diazepam, acetaminophen, ketamine, hyoscine butylbromide, propofol, dexamethasone and amoxycillin, and received parenteral nutrition. As the source of pain remained unclear, a second esophagoduodenoscopy was performed to determine a diagnosis, resulting in pain relief. Thus, in the present case, esophagoduodenoscopy was diagnostic and therapeutic. Furthermore, although the treatment of acute chest pain may be a challenge in palliative care, the present study indicates that pain treatment should be adjusted to anatomical, pathophysiological and pharmacological factors, and may pose risks due to the unavoidable parenteral co-administration of multiple agents with strong therapeutic effects.
authors: Palliative Medicine In-patient Unit, University Hospital of Lord's Transfiguration, Poznan 60-806, Poland ; Department of Pharmacology, Poznan University of Medical Sciences, Poznan 60-806, Poland.
authors: Iwona
authors: I
authors: Zaporowska-Stachowiak
authors: Palliative Medicine In-patient Unit, University Hospital of Lord's Transfiguration, Poznan 60-806, Poland ; Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan 60-806, Poland.
authors: Lidia
authors: L
authors: Gorzelińska
authors: Palliative Medicine In-patient Unit, University Hospital of Lord's Transfiguration, Poznan 60-806, Poland ; Chair and Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan 60-806, Poland.
authors: Maciej
authors: M
authors: Sopata
authors: Palliative Medicine In-patient Unit, University Hospital of Lord's Transfiguration, Poznan 60-806, Poland.
authors: Jacek
authors: J
authors: Łuczak
keywords: chest pain; epigastric pain; palliative care; stomach cancer